Gaye Ebru Şeker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gaye Ebru Şeker has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Ali Alagöz
Department of Anesthesiology and Reanimation, University of Health Sciences, Ankara Atatürk Sanatorium Training and Research Hospital, Ankara, Turkey
1 shared publication Duray Şeker
Department of General Surgery, Ministry of Health, Ankara Etlik City Hospital, Ankara
1 shared publication- Emine Arık
Department of Anesthesiology and Reanimation, University of Health Sciences, Ankara Etlik City Hospital, Ankara, Turkey
1 shared publication - Ezgi Güngördü
Department of Anesthesiology and Reanimation, University of Health Sciences, Ankara Etlik City Hospital, Ankara, Turkey
1 shared publication - Jülide Ergil
University of Health Sciences Türkiye, Ankara Etlik City Hospital, Clinic of Anaesthesiology and Reanimation, Ankara, Türkiye
1 shared publication - Musa Zengin
Department of Anesthesiology and Reanimation, University of Health Sciences, Ankara Etlik City Hospital, Ankara, Turkey
1 shared publication
Latest Publications
- Open Access
- 29 November 2025
- Published by Springer Nature in BMC Anesthesiology
- Vol. 26 (1)
Is the serratus posterior superior intercostal plane block a viable alternative to the erector spinae plane block for postoperative analgesia in breast surgery? A prospective, randomized trial
Effective management of postoperative pain remains a significant challenge after breast surgery. Among the available strategies, regional nerve blocks play
- 29 November 2025
- Published by Springer Nature in BMC Anesthesiology
- Vol. 26 (1)
Open AccessIs the serratus posterior superior intercostal plane block a viable alternative to the erector spinae plane block for postoperative analgesia in breast surgery? A prospective, randomized trial
Effective management of postoperative pain remains a significant challenge after breast surgery. Among the available strategies, regional nerve blocks play
- Open Access
- 27 August 2025
- Published by PAGEPress Publications in Emergency Care Journal
- Vol. 21 (3)
L-lactate in acute mesenteric ischemia: a reliable biomarker for diagnosis and prognosis?
Acute mesenteric ischemia is a life-threatening condition with high mortality, often caused by arterial or venous hypoperfusion of the intestines. Early diagnosis remains challenging due to nonspecific clinical findings and the unreliability of laboratory biomarkers. Serum L-lactate, a marker of tissue hypoperfusion, has been investigated as a potential prognostic and diagnostic indicator in acute mesenteric ischemia. This retrospective study analyzed 75 patients who underwent emergency surgery for acute mesenteric ischemia between 2010 and 2015. Demographic data, comorbidities, preoperative serum L-lactate levels, operative details, intestinal resection length, and survival outcomes were collected and statistically evaluated. ROC analysis was used to assess the diagnostic power of L-lactate in predicting the extent of bowel resection and to define a cut-off value. The overall mortality rate was 62.7%. Mortality was significantly associated with age ≥65 (p=0.011) and the presence of diabetes mellitus (p=0.041). Preoperative serum L-lactate levels were significantly higher in non-survivors than in survivors (median: 4.88 mmol/L vs. 3.00 mmol/L; p=0.011). However, no significant correlation was found between L-lactate levels and bowel resection length (p=0.316). ROC analysis failed to identify a statistically significant cut-off value for L-lactate in predicting resection extent (AUC=0.580; p=0.316). Preoperative serum L-lactate levels are significantly associated with mortality in patients with acute mesenteric ischemia and may serve as a prognostic biomarker. However, they do not reliably predict the extent of intestinal resection. Larger, prospective studies are required to define clinically meaningful diagnostic thresholds for L-lactate in acute mesenteric ischemia.
- 27 August 2025
- Published by PAGEPress Publications in Emergency Care Journal
- Vol. 21 (3)
Open AccessL-lactate in acute mesenteric ischemia: a reliable biomarker for diagnosis and prognosis?
Acute mesenteric ischemia is a life-threatening condition with high mortality, often caused by arterial or venous hypoperfusion of the intestines. Early diagnosis remains challenging due to nonspecific clinical findings and the unreliability of laboratory biomarkers. Serum L-lactate, a marker of tissue hypoperfusion, has been investigated as a potential prognostic and diagnostic indicator in acute mesenteric ischemia. This retrospective study analyzed 75 patients who underwent emergency surgery for acute mesenteric ischemia between 2010 and 2015. Demographic data, comorbidities, preoperative serum L-lactate levels, operative details, intestinal resection length, and survival outcomes were collected and statistically evaluated. ROC analysis was used to assess the diagnostic power of L-lactate in predicting the extent of bowel resection and to define a cut-off value. The overall mortality rate was 62.7%. Mortality was significantly associated with age ≥65 (p=0.011) and the presence of diabetes mellitus (p=0.041). Preoperative serum L-lactate levels were significantly higher in non-survivors than in survivors (median: 4.88 mmol/L vs. 3.00 mmol/L; p=0.011). However, no significant correlation was found between L-lactate levels and bowel resection length (p=0.316). ROC analysis failed to identify a statistically significant cut-off value for L-lactate in predicting resection extent (AUC=0.580; p=0.316). Preoperative serum L-lactate levels are significantly associated with mortality in patients with acute mesenteric ischemia and may serve as a prognostic biomarker. However, they do not reliably predict the extent of intestinal resection. Larger, prospective studies are required to define clinically meaningful diagnostic thresholds for L-lactate in acute mesenteric ischemia.